BioSpace News Archive

Teva has initiated a search to identify its next CFO. Mr. McClellan is expected to remain in his role through the announcement of third quarter results to assist with a smooth transition.

Strengthened balance sheet with US$5 million subordinated secured loan facility in July

The global hepatitis C drugs market size is poised to decline by USD billion during 2019-2023, according to a new report by Technavio, decelerating at a CAGR of close to% over the forecast period.

Rimegepant is the only oral CGRP receptor antagonist currently in development for both the acute and preventive treatment of migraine

Revenues of $4.3 billion

Nasdaq has granted the Company’s request for continued listing of the Company’s stock on the Nasdaq Stock Market.

Nordson MARCH, a division of Nordson (NASDAQ:NDSN), a global leader in plasma processing technology, will present the paper, “Plasma Applications for Wafer Level Packaging, Part 1,” at the 20th annual International Conference on Electronic Packaging Technology (ICEPT) in Hong Kong 11-15 August 2019.

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced the appointment of Hugh M. Cole to its Board of Directors.

Synaptive Medical Inc., a leader in transforming how surgeons access and use enriched patient data, announced today that Cameron Piron, President and Chief Strategy Officer, will present an overview of the Company and its business strategy during the Canaccord Genuity 39th Annual Growth Conference taking place August 7-8, 2019 in Boston, MA.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that The University of New Mexico (UNM) Comprehensive Cancer Center and the New Mexico Alliance for Cancer Care will utilize Personalis’ cancer immunogenomics platform, ImmunoID NeXT™